BioPharma Dive May 1, 2026 Bristol Myers’ legacy lift, Biogen’s blue skies and Regeneron’s murky outlook
BioPharma Dive Apr 30, 2026 UniQure, in ‘symbolic’ win, to seek UK approval of Huntington’s gene therapy